On 2/18/25, aTyr Pharma Inc (NASDAQ: ATYR) stock enjoyed a major increase of 11.1%, closing at $3.79. Moreover, trading volume in this advance was unusually high at 154% of normal. The stock has been exceptionally strong relative to the market over the last nine months but has declined -2.8% during the last week.
Current PriceTarget Research Rating
aTyr Pharma has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. aTyr Pharma has a poor Appreciation Score of 20 but a very high Power Rating of 91, resulting in the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment